| Document |
Document Title |
|
WO/1998/035954A1 |
Compounds of Formula (I), and their $i(N)-oxides and agriculturally suitable salts, are disclosed which are useful for controlling undesired vegetation wherein Q is Q-1, Q-2, Q-3 or Q-4; and Q, Z, X, R?1� through R?20�, m, n, and r a...
|
|
WO/1998/035963A1 |
This invention relates to a process for preparing eprosartan.
|
|
WO/1998/032733A1 |
A compound of formula (I) wherein R?1� and R?2� are as defined in the description, R?2� being an aromatic group, useful in the treatment and condition selected from the group consisting of the group meningitis and salpingitis, sept...
|
|
WO/1998/029406A1 |
Cyclohexanedione derivatives represented by general formula (I), salts thereof, and herbicides containing the same as the active ingredients. These chemicals do not injure upland field crops such as corn in both soil treatment and foliag...
|
|
WO/1998/029383A1 |
The invention concerns 2-benzoyl-cyclohexan-1,3-diones of formula (I), in which R?1�, R?2� stand for hydrogen, nitro, halogen, cyano, rhodano, alkyl, halogen alkyl, alkoxyalkyl, alkenyl, alkinyl, -OR?5�, -OCOR?6�, -OSO�2?R?6�...
|
|
WO/1998/028291A1 |
Compounds of Formula (I) are disclosed which are useful for controlling undesired vegetation wherein Q is (Q-1) or (Q-2); and R?1�-R?12�, M, m, n, p, q, r, and t are as defined in the disclosure. Also disclosed are compositions conta...
|
|
WO/1998/027080A1 |
Compounds of formula (I) in which Z is O, S(O)�n? or NR, and a) P is WR?2�; and Q is R?1� or W?2�R?2a� or b) P is R?a� and Q is R?b�; and when Z is S(O)�n? or NR, and Q is W?2�R?2a�; P can be R?1�; W and W?2�, whi...
|
|
WO/1998/025616A1 |
This invention provides methods for the treatment or prevention of cerebral focal ischemia which comprises administering to a mammal in need thereof an effective amount of a compound having activity as a leukotriene B�4? antagonist.
|
|
WO/1998/025875A1 |
Compounds of the formula (1) where the symbols have the meaning defined in the specification, have retinoid, retinoid antagonist and/or retinoid inverse-agonist-like biological activity.
|
|
WO/1998/025916A1 |
The present invention relates to a novel benzopyran derivative having anti-estrogenic activity. More specifically, the present invention relates to a novel benzopyran derivative represented by formula (I) and pharmaceutically acceptable ...
|
|
WO/1998/022432A1 |
Acylamino-substituted acylanilide derivatives represented by general formula (I) or salts thereof, and a pharmaceutical composition comprising the same. They have an antiandrogenic activity and are useful as a prophylactic or therapeutic...
|
|
WO/1998/022434A1 |
The invention relates to novel glyoxylic acid amides, a method for the production and the use thereof as pesticides.
|
|
WO/1998/017630A1 |
The invention relates to novel amides of the general formula (I), a method for their production and their use as pesticides.
|
|
WO/1998/014418A1 |
Liqud crystal compounds and liquid crystal compositions which are best suited as a liquid crystal material required to have negative permittivity including an IPS mode. The compounds are represented by general formulae (1) and (1-1), whe...
|
|
WO/1998/013361A1 |
The present invention relates to new compounds of formula (I) wherein R�1? to R�3?, U, V, W, Z and m have the significances given in the description, their use as antidotes in herbicidal compositions for the control of weeds and gras...
|
|
WO/1998/011886A1 |
The invention concerns the use of inhibitors of retinoic acid activity, such as the RAR antagonists, for healing wounds, particularly of the skin.
|
|
WO/1998/007716A2 |
Anticancer compositions having receptor specificity as well as activity in stimulating formation of the enzyme transglutaminase as a marker for anticancer activity. The compositions comprise certain heteroarotinoid structures partially r...
|
|
WO/1998/004247A1 |
The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds...
|
|
WO/1998/004247A2 |
The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds...
|
|
WO/1998/004913A1 |
Pharmacophore models of VLA-4 inhibitors, methods of identifying novel inhibitors and novel inhibitors identified by these methods.
|
|
WO/1997/049664A1 |
A compound for use as a photoinitiator comprises a photoreactive portion and a pendent group, said photoreactive portion including an aromatic moiety and said pendent group incorporating at least one optionally-substituted poly(alkylene ...
|
|
WO/1997/046548A1 |
A compound having structure (I) wherein (a) X is selected from the group consisting of O, S, SO, or SO2; (b) each Y is independently hydrogen or straight, branched or cyclic alkanyl having from 1 to about 4 carbon atoms, or the two Y's a...
|
|
WO/1997/046511A1 |
Method and compositions for treating a patient having a neurological disease or disorder, such as stroke, head trauma, spinal cord injury, spinal cord ischemia, ischemia- or hypoxia-induced nerve cell damage, epilepsy, anxiety, neuropsyc...
|
|
WO/1997/044364A1 |
Novel substituted diaryl ketones, photopolymerization compositions including the compounds, and methods using the same are disclosed. Polymerization of compositions which include the compounds of the invention may be activated by irradia...
|
|
WO/1997/041110A1 |
A process for preparing thioxanthone and derivatives thereof is disclosed. In the process, an aromatic compound, such as cumene, is reacted with thiosalicylic acid (TSA) or dithiosalicylic acid (DTSA) in the presence of sulfuric acid. Th...
|
|
WO/1997/033862A1 |
A compound of formula (I) wherein R is a) phenyl; phenyl (C1-C4 alkoxy); phenoxy; or benzyl; the phenyl ring of each substituent being optionally substituted with one or more of halogen, nitro, C1-C8 alkyl, C1-C8 alkoxy, C1-C8 haloalkyl,...
|
|
WO/1997/033881A1 |
Novel bicyclic-aromatic compounds having general formula (I), and the use thereof in pharmaceutical compositions useful in human or veterinary medicine (in particular for the treatment of dermatological, rheumatic, respiratory, cardiovas...
|
|
WO/1997/031904A1 |
The invention concerns compounds of formula (I) and their salts which are suitable as herbicides and plant growth regulators, R1 to R6, Y1, Y2, Y3, m and n being defined as in claim 1. These compounds can be prepared in similar manner to...
|
|
WO/1997/029101A1 |
Novel cyclic amino acids of formula (Ia) or (Ib) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, and n...
|
|
WO/1997/028148A1 |
A compound having structure (I) wherein (a) n is from 1 to about 3; (b) X is selected from the group consisting of O, S, SO, or SO2; (c) Y is independently hydrogen or straight, branched or cyclic alkyl having from about 1 to about 4 car...
|
|
WO/1997/028146A1 |
A compound having structure (I) wherein (a) n is from about 1 to about 3; (b) X is selected from the group consisting of O, S, SO, or SO2; (c) Y is independently hydrogen or straight, branched or cyclic alkyl having from 1 to about 4 car...
|
|
WO/1997/028143A1 |
A compound having structure (I) wherein (a) n is from 1 to about 3; (b) X is selected from the group consisting of O, S, SO, or SO2; (c) Y is independently hydrogen or straight, branched or cyclic alkyl having from 1 to about 4 carbon at...
|
|
WO/1997/026237A1 |
Novel aromatic polycyclic retinoid-type derivatives of general formula (I), wherein groupings R3 and R4 attached to the double bond between carbons 11 and 12 are cis groupings, and pharmaceutical and cosmetic compositions containing same...
|
|
WO/1997/026240A1 |
Novel compounds are provided which are inhibitors of MTP and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases, and have the structure (I) or (IA) or (IB) including pharmaceutically acceptable sa...
|
|
WO/1997/024348A1 |
Compounds of formula (1) where R1, R2, R3 and R4 independently are H or lower alkyl of 1 to 10 carbons; R5 is lower alkyl of 1 to 10 carbons, fluoro, chloro, bromo, iodo, nitro or fluoroalkyl having 1 to 10 carbons; m is an integer havin...
|
|
WO/1997/023476A1 |
Cyclic sulphones of formula (I) are disclosed, in which: R1 and R2 each independently of one another stand for H, A, CF3, CH2F, CHF2, C2F5, Hal, OH, OA, NH2, NHA, NA2, NO2 or CN; X stands for CR4R5, C=Z, O, S, NH, NA or NR3; Y stands for...
|
|
WO/1997/020807A1 |
The invention relates to herbicidally active cyclohexenone oxime ether metal salts of formula (I), in which Rn is C1-Cn-alkyl and Rb is the equivalent of an alkali metal, an alkaline earth metal or a transition metal. The claimed salts h...
|
|
WO/1997/019052A1 |
Compounds of formula (I) where X is S, O, NR' where R' is H or alkyl of 1 to 6 carbons, or X is [C(R1)2]n where n is an integer between 0 and 2; 1; Y is a phenyl or naphthyl group, or heteroaryl group; W is a substituent selected from th...
|
|
WO/1997/019071A1 |
The disclosure relates to phenyl diketone derivatives of formula I in which the substituents have the following meanings: L, M - hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkinyl, C1-C4 alkoxy (these groups being optionally substituted...
|
|
WO/1997/019087A1 |
Compounds of Formula (I), and their N-oxides and agriculturally-suitable salts, are disclosed which are useful for controlling undesired vegetation, wherein J is Formula (II) and Q, X, Y, Z, R1-R19, m, n, p, q and r are as defined in the...
|
|
WO/1997/016183A1 |
The present invention relates to morphinan derivatives that are neuroprotective against excitatory amino acid (EAA) cytotoxicity. In particular, morphinan derivatives of the invention act as antagonists at the ionotropic NMDA (N-methyl-(...
|
|
WO/1997/013765A1 |
2-cyano-1,3-dione derivatives represented by general formula (I), a process for producing the same, and herbicides containing the same as the active ingredient, wherein R1 represents C1-6 alkyl, C3-6 cycloalkyl or -(CH2)q-OR6 (wherein q ...
|
|
WO/1997/012862A1 |
Analogs of the antitumor antibiotics CC-1065 and the duocarmycins incorporate the 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) alkylation subunit. The CBI-based analogs have potent cytotoxic activity and are useful as efficac...
|
|
WO/1997/010809A1 |
Disclosed are reconstituted lyophilized formulations for the treatment of mammalian tumors comprising a thioxanthenone antitumor agent in combination with mannitol or sucrose as a stabilizer in a lactate buffer.
|
|
WO/1997/009324A1 |
Benzoyl derivatives according to formula (I), where substituents L, M, X, Y and n have the meaning given in claim 1 and Q stands for a 2-position cross-linked cyclohexane-1,3-dione ring according to formula (II), where R15, R16, R18, and...
|
|
WO/1997/009297A2 |
Aryl-substituted and aryl and (3-oxo-1-propenyl)-substituted benzopyran, benzothiopyran, 1,2-dihydroquinoline, and 5,6-dihydronaphthalene derivatives have retinoid negative hormone and/or antagonist-like biological activities. The invent...
|
|
WO/1997/009327A1 |
The invention concerns pyrazol-4-yl-benzoyl derivatives of formula (I) in which the substituents L, M, X, Y, and n have the meanings given in claim 1, and Q is a pyrazol ring which is bonded in position 4 and corresponds to formula (II),...
|
|
WO/1997/008164A1 |
Compounds of Formula (I), and their agriculturally suitable salts, are disclosed which are useful for controlling undesired vegetaion, wherein Q is (Q-1) or (Q-2); and A, Y, Z, R1-R7, q and r are as defined in the disclosure. Also disclo...
|
|
WO/1997/008163A1 |
A process for easily producing alkoxythiochroman-carboxylic acids, which are used in the production of pyrazole derivatives having a thiochroman ring and useful as a herbicide, via the hydrolysis of alkoxythiochroman-carboxylic acid este...
|
|
WO/1997/005101A1 |
A photoactive compound of general formula (I) that is the reaction of an alkenyl azalactone compound and a nucleophilic aromatic ketone is described. Mer units derived from this compound can be used, for example, to crosslink via a hydro...
|
